KromaTiD
Longmont, US · Founded 2022 · Delaware corporation
Founders & leadership
AJ
Andrew JostExecutive Officer
JC
James ChomasExecutive Officer, Director
SB
Susan BaileyExecutive Officer
NS
Nick SaccomanoDirector
JB
Joel BedfordDirector
GO
Ginny OrndorfDirector
CT
Christopher TompkinsExecutive Officer, Director
TO
Terry OpgenorthDirector
JB
Jack BallDirector
PG
Priyadarshini GogoiDirector
WY
Walter YoungDirector
Reported raises · per SEC filings
Form D private placements▶$3.6MraisedJul 2025 · 57 investors · OtherRule 506(b)
▶$3.6MraisedJul 2025 · 57 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Andrew JostExecutive Officer
- Jack BallDirector
- James ChomasExecutive Officer, Director
- Priyadarshini GogoiDirector
- Walter YoungDirector
- Terry OpgenorthDirector
- Offering amount
- $5M
- Amount sold
- $3.6M
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$2.1MraisedJan 2024 · 63 investors · OtherRule 506(b)
▶$2.1MraisedJan 2024 · 63 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- ANDREW JOSTExecutive Officer
- JACK BALLDirector
- TERRY OPGENORTHDirector
- WALTER YOUNGDirector
- JAMES CHOMASDirector
- DAVID BRUNELDirector
- PRIYADARSHINI GOGOIDirector
- NATHAN WOODExecutive Officer, Director
- Offering amount
- $4.2M
- Amount sold
- $2.1M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$7.9MraisedOct 2021 · 61 investors · OtherRule 506(b)
▶$7.9MraisedOct 2021 · 61 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- David BrunelDirector
- Walter YoungDirector
- Priyadarshini GogoiDirector
- Nathan WoodExecutive Officer, Director
- James ChomasDirector
- Vic MyerDirector
- Terry OpgenorthDirector
- Offering amount
- $10M
- Amount sold
- $7.9M
- First sale
- Sep 2021
- Incorporated
- Corporation, Colorado
- Federal exemptions
- 06b
▶$1.9MraisedAug 2019 · 4 investors · OtherRule 506(b)
▶$1.9MraisedAug 2019 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Christopher TompkinsExecutive Officer, Director
- Terry OpgenorthDirector
- Joel BedfordDirector
- Ginny OrndorfDirector
- Nick SaccomanoDirector
- Gordon LinkExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.9M
- First sale
- Feb 2019
- Incorporated
- Corporation, Colorado
- Federal exemptions
- 06b
▶$622.7KraisedJan 2017 · 16 investors · OtherRule 506(b)
▶$622.7KraisedJan 2017 · 16 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Susan BaileyExecutive Officer
- Nick SaccomanoDirector
- Joel BedfordDirector
- Ginny OrndorfDirector
- Christopher TompkinsExecutive Officer, Director
- Terry OpgenorthDirector
- Offering amount
- $1M
- Amount sold
- $622.7K
- First sale
- Dec 2016
- Incorporated
- Corporation, Colorado
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $700.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $206.6K |
| NASA | Phase II | 2010 | $600K |
| NASA | Phase I | 2009 | $100K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.